South Korea’s Reform to Boost Doctors’ Numbers Backfires with Walkouts
India: An Attractive Proposition for Global Pharma’s Latest Innovations?
Ipsen’s Aggressive M&A Strategy Pays Off with “New Era of Dynamic Growth”
Ex Novartis Oncology Lead Susan Schaffert Back in Big Pharma with Merck
Clinical Trials: France Strives to Remain Among Europe’s Top Three
Clinical Trials in Portugal: The Next Steps
US Drug Pricing and Reimbursement: Players, Payers, PBMs, and Prospects
Drug Shortages in the Global South: A Proposed Parallel Tech and Reg Transfer Framework
EU Pharma Legislation: An Opportunity to Rethink
New US ‘Biosecure Act’ to Target Chinese Biotechs WuXi and BGI
2023: A Pivotal Year for SwissMedic
China Pharma News: US Bill Pinpoints WuXi as “Foreign Adversary Biotech;” Novartis Acquires SanReno
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here